30.05.2023 - GERMANTOWN, Md., May 30, 2023 (GLOBE NEWSWIRE) - Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today announced that cell and gene ... Seite 1